Amarin Corp Plcuk (AMRN) Total Debt (QoQ) (2011 - 2020)
Amarin Corp Plcuk (AMRN) Total Debt (QoQ) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -57.84% |
| Jun 30, 2020 | -39.27% |
| Mar 31, 2020 | -26.24% |
| Dec 31, 2019 | -16.51% |
| Sep 30, 2019 | -12.49% |
| Jun 30, 2019 | -7.65% |
| Mar 31, 2019 | -7.53% |
| Dec 31, 2018 | 173.50% |
| Sep 30, 2018 | -0.70% |
| Jun 30, 2018 | -44.62% |
| Mar 31, 2018 | 4.05% |
| Dec 31, 2017 | 76.08% |
| Sep 30, 2017 | -63.43% |
| Jun 30, 2017 | -19.79% |
| Mar 31, 2017 | -1.09% |
| Dec 31, 2016 | 646.09% |
| Sep 30, 2016 | -91.39% |
| Jun 30, 2016 | 49.38% |
| Mar 31, 2016 | -29.80% |
| Dec 31, 2015 | 42.10% |